NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.
NeuExcell Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
NeuExcell Therapeutics's investors include Foothill Ventures, BioVenture, Innoangel Fund, Guangzhou Financial Holding Fund Management, Cowin Venture.
NeuExcell Therapeutics is headquartered in State College, United States.
NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.
NeuExcell Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuExcell Therapeutics — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/neuexcell-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). NeuExcell Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/neuexcell-therapeutics
{{cite web |title=NeuExcell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuexcell-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated